Chondroitin Sulphate Inhibits Monocyte Chemoattractant Protein-1 Release from 3T3L1 Adipocytes: A New Treatment Opportunity for Obesity-related Metabolic Syndromes?

Volume: 25, Pages: S272 - S272
Published: Apr 1, 2017
Abstract
Purpose: Monocyte chemoattractant protein-1(MCP-1) overproduction from inflamed adipose tissue is a major contributor to obesity-related metabolic syndromes. We have recently published that chondroitin sulphate (CS) can attenuate the MSU crystal mediated THP-1 macrophage inflammatory response reflected by reduced release of pro-inflammatory cytokines IL-1β and TNFα. We have also recently determined that the CS inhibitory effect is not acting at...
Paper Details
Title
Chondroitin Sulphate Inhibits Monocyte Chemoattractant Protein-1 Release from 3T3L1 Adipocytes: A New Treatment Opportunity for Obesity-related Metabolic Syndromes?
Published Date
Apr 1, 2017
Volume
25
Pages
S272 - S272
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.